Home › Funds › Greenhaven Road Investment Management, L.P. › LFCR

Greenhaven Road Investment Management, L.P. position in LFCR

LIFECORE BIOMEDICAL INC · Health Care

Greenhaven Road Investment Management, L.P. reported holding 2,868,881 shares of LFCR (LIFECORE BIOMEDICAL INC) in its Q3 2026 13F filing — a position valued at US$18.9M, representing 16.25% of its reported portfolio and ranking #1 among its reported holdings. Greenhaven Road Investment Management, L.P. has disclosed LFCR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)2.87M sh
Reported value held$18.88M
Portfolio Weight16.25%
First reportedQ3 2023
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Greenhaven Road Investment Management, L.P.'s LFCR position evolved

Greenhaven Road Investment Management, L.P. first disclosed a stake in LFCR in Q3 2023 at 2,193,333 shares (US$165.5M). Across 13 filings, Greenhaven Road Investment Management, L.P. increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 2,868,881 shares valued at US$18.9M — a reduction of -321,888 shares quarter over quarter.. Notable position changes include a 62% increase in Q4 2024 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.19M $165.49M New
Q4 2023 2.37M $14.65M Add
Q1 2024 2.14M $11.38M Reduce
Q2 2024 2.22M $11.37M Add
Q3 2024 2.23M $10.99M Add
Q4 2024 3.62M $26.87M Add
Q1 2025 3.62M $25.46M Hold
Q2 2025 3.69M $30.00M Add
Q3 2025 3.69M $27.19M Hold
Q4 2025 3.68M $30.12M Hold
Q1 2026 3.54M $13.16M Reduce
Q2 2026 3.19M $16.75M Reduce
Q3 2026 2.87M $18.88M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LFCR and 13F data

LFCR (LIFECORE BIOMEDICAL INC) is a Health Care company. 20 other funds we track also report a position in LFCR — the largest reported positions include WYNNEFIELD CAPITAL INC (US$24.7M), Legion Partners Asset Management, LLC (US$23.4M), 325 CAPITAL LLC (US$15.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LFCR

All LFCR fund holders →

FAQ

How long has Greenhaven Road Investment Management, L.P. held LFCR?

Greenhaven Road Investment Management, L.P. has disclosed LFCR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Greenhaven Road Investment Management, L.P.'s current position in LFCR?

As of Q3 2026, Greenhaven Road Investment Management, L.P. holds 2.87M shares of LFCR (LIFECORE BIOMEDICAL INC), valued at $18.88M, representing 16.25% of its reported portfolio and ranking #1.

Has Greenhaven Road Investment Management, L.P. been buying or selling LFCR?

In the latest 13F filing (Q3 2026), Greenhaven Road Investment Management, L.P. reduced its position in LFCR.

Which other funds hold LFCR?

Other major institutional holders of LFCR include WYNNEFIELD CAPITAL INC, Legion Partners Asset Management, LLC, 325 CAPITAL LLC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.